GSK plc

GSK

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical company headquartered in London, England.

About GSK plc

Share price for GSK plc

LON: GSK Dividends

Historical Data

Latest GSK plc News

GSK PLC reports strong Q1 2025 results, driven by Specialty Medicines growth and significant R&D investments, highlighting confidence in future...
GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses....
GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million...
GSK plc has completed its acquisition of IDRx, Inc., aiming to advance treatments for gastrointestinal stromal tumours with the novel...
GSK's Penmenvy vaccine wins FDA approval, offering protection for ages 10-25 against five major meningococcal serogroups, aiming to boost vaccination...
GSK plc reports robust 2024 performance with strong Specialty Medicines growth, promising R&D advancements, and strategic shareholder returns....

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.